CN103901116B - 盐酸法舒地尔中杂质高哌嗪的检测分析方法 - Google Patents
盐酸法舒地尔中杂质高哌嗪的检测分析方法 Download PDFInfo
- Publication number
- CN103901116B CN103901116B CN201210571001.2A CN201210571001A CN103901116B CN 103901116 B CN103901116 B CN 103901116B CN 201210571001 A CN201210571001 A CN 201210571001A CN 103901116 B CN103901116 B CN 103901116B
- Authority
- CN
- China
- Prior art keywords
- homopiperazine
- impurity
- solution
- fasudic hydrochloride
- determination method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Treatment Of Liquids With Adsorbents In General (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210571001.2A CN103901116B (zh) | 2012-12-26 | 2012-12-26 | 盐酸法舒地尔中杂质高哌嗪的检测分析方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210571001.2A CN103901116B (zh) | 2012-12-26 | 2012-12-26 | 盐酸法舒地尔中杂质高哌嗪的检测分析方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103901116A CN103901116A (zh) | 2014-07-02 |
CN103901116B true CN103901116B (zh) | 2017-02-08 |
Family
ID=50992575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210571001.2A Active CN103901116B (zh) | 2012-12-26 | 2012-12-26 | 盐酸法舒地尔中杂质高哌嗪的检测分析方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103901116B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105866263B (zh) * | 2016-03-24 | 2018-06-29 | 四川升和药业股份有限公司 | 一种盐酸法舒地尔的质量控制方法 |
CN108459106B (zh) * | 2018-04-26 | 2021-01-26 | 南京明捷生物医药检测有限公司 | 一种测定盐酸法舒地尔中高哌嗪含量的方法 |
CN109557205B (zh) * | 2018-11-30 | 2021-10-29 | 成都倍特药业股份有限公司 | 从盐酸法舒地尔中检测高哌嗪的方法 |
CN110441449B (zh) * | 2019-08-14 | 2021-06-29 | 昆药集团股份有限公司 | 盐酸法舒地尔原料或注射剂中有关物质的检测方法 |
CN112748197B (zh) * | 2020-12-23 | 2022-08-05 | 上海微谱化工技术服务有限公司 | 药物中杂质高哌嗪的准确定量测定方法 |
CN113447584A (zh) * | 2021-06-28 | 2021-09-28 | 山西省检验检测中心(山西省标准计量技术研究院) | 一种盐酸法舒地尔注射液中高哌嗪的检测分析方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101008637A (zh) * | 2007-01-11 | 2007-08-01 | 天津红日药业股份有限公司 | 一种盐酸法舒地尔注射液的质量控制方法 |
CN102706997A (zh) * | 2012-06-28 | 2012-10-03 | 武汉武药科技有限公司 | 盐酸法舒地尔有关物质的检测方法 |
-
2012
- 2012-12-26 CN CN201210571001.2A patent/CN103901116B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101008637A (zh) * | 2007-01-11 | 2007-08-01 | 天津红日药业股份有限公司 | 一种盐酸法舒地尔注射液的质量控制方法 |
CN102706997A (zh) * | 2012-06-28 | 2012-10-03 | 武汉武药科技有限公司 | 盐酸法舒地尔有关物质的检测方法 |
Non-Patent Citations (5)
Title |
---|
HPLC法测定盐酸法舒地尔的含量及有关物质;郭旭光;《中国药事》;20061221;第26卷(第12期);1380-1383 * |
HPLC测定马来酸法舒地尔注射液中马来酸法舒地尔含量和有关物质;方金玲;《中国药学杂志》;20060930;第41卷(第18期);1417-1419 * |
盐酸法舒地尔;国家食品药品监督管理局;《新药标准转正》;20061231;第73卷;131-132 * |
盐酸法舒地尔有关物质的色谱-质谱结构鉴定;陈月琴;《2012年中国药学大会暨第十二届中国药师周论文集》;20121119;1-8 * |
盐酸法舒地尔有机杂质的分析和控制;石靖,许真玉;《中国新药杂志》;20130831;第22卷(第16期);1878-1881 * |
Also Published As
Publication number | Publication date |
---|---|
CN103901116A (zh) | 2014-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103901116B (zh) | 盐酸法舒地尔中杂质高哌嗪的检测分析方法 | |
Ranjbari et al. | Preconcentration of trace amounts of methadone in human urine, plasma, saliva and sweat samples using dispersive liquid–liquid microextraction followed by high performance liquid chromatography | |
CN108593831B (zh) | 盐酸法舒地尔有关物质的hplc检测方法 | |
Roda et al. | Determination of acid dissociation constants of compounds active at neuronal nicotinic acetylcholine receptors by means of electrophoretic and potentiometric techniques | |
CN108398507A (zh) | 一种盐酸法舒地尔杂质5-异喹啉磺酸甲酯的高效液相色谱分析检测方法 | |
Nirogi et al. | Approach to reduce the non-specific binding in microdialysis | |
Cai et al. | Polyoxometalate incorporated polymer monolith microextraction for highly selective extraction of antidepressants in undiluted urine | |
CN108459106A (zh) | 一种测定盐酸法舒地尔中高哌嗪含量的方法 | |
CN106338564B (zh) | 一种用于检测维格列汀中间体中对映异构体的方法 | |
CN105866263B (zh) | 一种盐酸法舒地尔的质量控制方法 | |
CN106033079A (zh) | 甲磺酸达比加群酯起始物料f中有关物质咪唑的检测方法 | |
CN109975435A (zh) | 一种沙芬酰胺中甲磺酸异丙酯含量的测定方法 | |
CN107121505A (zh) | 一种测定达巴万星杂质的方法 | |
Kehr et al. | Determination of the dopamine agonist rotigotine in microdialysates from the rat brain by microbore column liquid chromatography with electrochemical detection | |
CN104764840B (zh) | 盐酸帕洛诺司琼及杂质的分离与检测方法 | |
Xu et al. | Development and validation of the quantitative determination of avapritinib in rat plasma by a bioanalytical method of UPLC-MS/MS | |
CN108872406A (zh) | 一种门冬氨酸原料药中有关物质的hplc分析检测方法 | |
CN104237399A (zh) | 测定安立生坦原料药及其制剂含量的方法 | |
CN105301118A (zh) | 一种枸橼酸莫沙必利有关物质的检测方法 | |
Pospíšilová et al. | Assay of acebutolol in pharmaceuticals by analytical capillary isotachophoresis | |
Ji et al. | Quantification of orelabrutinib in human plasma and cerebrospinal fluid by liquid chromatography tandem mass spectrometry | |
Santos et al. | Determination of scopolamine and butylscopolamine in beverages, urine and Buscopan® tablets samples using electrophoresis microchip with integrated contactless conductivity detection | |
Patel et al. | Analytical methodologies for determination of telmisartan: an overview | |
CN109239208A (zh) | 一种盐酸曲恩汀的质量检测方法 | |
CN106950314A (zh) | 一种检测罗库溴铵或其注射液中烯丙基溴含量的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 221004 No. 6, Yang Shan Road, Jinshan Development Zone, Jiangsu, Xuzhou Co-patentee after: SHANGHAI FOSUN PHARMACEUTICAL(GROUP)CO., Ltd. Patentee after: JIANGSU WANBANG BIOPHARMACEUTICAL GROUP CO.,LTD. Address before: 221004 No. 6, Yang Shan Road, Jinshan Development Zone, Jiangsu, Xuzhou Co-patentee before: SHANGHAI FOSUN PHARMACEUTICAL(GROUP)CO., Ltd. Patentee before: Jiangsu Wan Bang Biochemical Medicine Co.,Ltd. Address after: 221004 No. 6, Yang Shan Road, Jinshan Development Zone, Jiangsu, Xuzhou Co-patentee after: SHANGHAI FOSUN PHARMACEUTICAL(GROUP)CO., Ltd. Patentee after: Jiangsu Wan Bang Biochemical Medicine Co.,Ltd. Address before: 221004 No. 6, Yang Shan Road, Jinshan Development Zone, Jiangsu, Xuzhou Co-patentee before: SHANGHAI FOSUN PHARMACEUTICAL(GROUP)CO., Ltd. Patentee before: JIANGSU WANBANG BIOPHARMACEUTICALS Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180214 Address after: 221004 Yangshan Road, Jinshui Bridge Economic Development Zone, Xuzhou, Xuzhou, Jiangsu Patentee after: JIANGSU WANBANG BIOPHARMACEUTICAL GROUP CO.,LTD. Address before: 221004 No. 6, Yang Shan Road, Jinshan Development Zone, Jiangsu, Xuzhou Co-patentee before: SHANGHAI FOSUN PHARMACEUTICAL(GROUP)CO., Ltd. Patentee before: JIANGSU WANBANG BIOPHARMACEUTICAL GROUP CO.,LTD. |